FAGAX
Price
$164.36
Change
-$0.78 (-0.47%)
Updated
May 9 closing price
Net Assets
22.34B
GAFFX
Price
$72.65
Change
-$0.09 (-0.12%)
Updated
May 9 closing price
Net Assets
285.87B
Ad is loading...

FAGAX vs GAFFX

Header iconFAGAX vs GAFFX Comparison
Open Charts FAGAX vs GAFFXBanner chart's image
Fidelity Advisor Growth Opps A
Price$164.36
Change-$0.78 (-0.47%)
VolumeN/A
Net Assets22.34B
American Funds Growth Fund of Amer F3
Price$72.65
Change-$0.09 (-0.12%)
VolumeN/A
Net Assets285.87B
FAGAX vs GAFFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FAGAX vs. GAFFX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAGAX is a Buy and GAFFX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 286B vs. FAGAX (22.3B). GAFFX pays higher dividends than FAGAX: GAFFX (0.70) vs FAGAX (0.00). FAGAX was incepted earlier than GAFFX: FAGAX (29 years) vs GAFFX (8 years). FAGAX (0.74) is less costly to investors than GAFFX (0.30). FAGAX is a more actively managed with annual turnover of: 56.00 vs. GAFFX (25.00). FAGAX has a lower initial minimum investment than GAFFX: FAGAX (0) vs GAFFX (1000000). FAGAX annual gain was more profitable for investors over the last year : 12.45 vs. GAFFX (3.51). FAGAX return over 5 years is better than : 74.95 vs. GAFFX (46.03).
FAGAXGAFFXFAGAX / GAFFX
Total Expense Ratio0.740.30247%
Annual Report Gross Expense Ratio0.740.30247%
Fund Existence29 years8 years-
Gain YTD-7.220-2.444295%
Front Load6%N/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets22.3B286B8%
Annual Yield % from dividends0.000.70-
Returns for 1 year12.453.51355%
Returns for 3 years70.5834.08207%
Returns for 5 years74.9546.03163%
Returns for 10 years149.80N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
PENN15.640.35
+2.29%
PENN Entertainment
CRL138.79-2.57
-1.82%
Charles River Laboratories International
ACRS1.26-0.05
-3.82%
Aclaris Therapeutics